Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
US military conducts eighth strike on alleged drug-trafficking vessel, raising scrutiny over legal justification and oversight.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
US military conducts eighth strike on alleged drug-trafficking vessel, raising scrutiny over legal justification and oversight.